These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2739903)

  • 61. Overlapping regional distribution of CCK and TPPII mRNAs in Cynomolgus monkey brain and correlated levels in human cerebral cortex (BA 10).
    Radu D; Tomkinson B; Zachrisson O; Weber G; de Belleroche J; Hirsch S; Lindefors N
    Brain Res; 2006 Aug; 1104(1):175-82. PubMed ID: 16822484
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Formation of [Leu5]enkephalin from dynorphin A(1-8) by rat central nervous tissue in vitro.
    Dixon DM; Traynor JR
    J Neurochem; 1990 Apr; 54(4):1379-85. PubMed ID: 1968961
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Extraction techniques for gastrins and cholecystokinins in the rat central nervous system.
    Marley PD; Rehfeld JF
    J Neurochem; 1984 Jun; 42(6):1515-22. PubMed ID: 6327905
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Tripeptidyl peptidase-I is essential for the degradation of sulphated cholecystokinin-8 (CCK-8S) by mouse brain lysosomes.
    Warburton MJ; Bernardini F
    Neurosci Lett; 2002 Oct; 331(2):99-102. PubMed ID: 12361850
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Dopamine modulates cholecystokinin release in neostriatum.
    Meyer DK; Krauss J
    Nature; 1983 Jan; 301(5898):338-40. PubMed ID: 6823307
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Stimulatory effect of phenylmethylsulfonyl fluoride upon sulfate uptake by costal cartilage.
    McKern NM
    Aust J Biol Sci; 1983; 36(1):35-40. PubMed ID: 6870669
    [TBL] [Abstract][Full Text] [Related]  

  • 67. External pH changes affect NMDA-evoked and spontaneous release of cholecystokinin, somatostatin and noradrenaline from rat cerebrocortical nerve endings.
    Gemignani A; Paudice P; Longordo F; Raiteri M
    Neurochem Int; 2004 Oct; 45(5):677-85. PubMed ID: 15234110
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Release of cholecystokinin from rat midbrain slices and modulatory effect of D2DA receptor stimulation.
    Freeman AS; Chiodo LA; Lentz SI; Wade K; Bannon MJ
    Brain Res; 1991 Aug; 555(2):281-7. PubMed ID: 1682000
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [125I][D-Tyr25,Nle28,31]CCK-(25-33): a convenient new aminopeptidase resistant cholecystokinin analogue for radioligand binding and autoradiography.
    Carlberg M; Beart PM; Jarrott B
    Eur J Pharmacol; 1990 Nov; 191(1):107-10. PubMed ID: 2092997
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Transport of cholecystokinin-octapeptide-like immunoreactivity toward the gut in afferent vagal fibres in cat and dog.
    Dockray GJ; Gregory RA; Tracy HJ; Zhu WY
    J Physiol; 1981 May; 314():501-11. PubMed ID: 6273537
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pig brain contains cholecystokinin octapeptide and several cholecystokinin desoctapeptides.
    Eng J; Shiina Y; Pan YC; Blacher R; Chang M; Stein S; Yalow RS
    Proc Natl Acad Sci U S A; 1983 Oct; 80(20):6381-5. PubMed ID: 6312456
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Brain cholecystokinin-8 immunoreactivity in rats with experimental liver cirrhosis.
    Salerno F; Bonato C; Panerai AE; Martini A; Malesci A
    Life Sci; 1983 Jul; 33(4):377-81. PubMed ID: 6308371
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Dipeptidyl peptidase II of bovine dental pulp. Initial demonstration and characterization as a fibroblastic, lysosomal peptidase of the serine class active on collagen-related peptides.
    McDonald JK; Schwabe C
    Biochim Biophys Acta; 1980 Nov; 616(1):68-81. PubMed ID: 7002217
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The final N-terminal trimming of a subaminoterminal proline-containing HLA class I-restricted antigenic peptide in the cytosol is mediated by two peptidases.
    Lévy F; Burri L; Morel S; Peitrequin AL; Lévy N; Bachi A; Hellman U; Van den Eynde BJ; Servis C
    J Immunol; 2002 Oct; 169(8):4161-71. PubMed ID: 12370345
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Identification of the active site residues in dipeptidyl peptidase IV by affinity labeling and site-directed mutagenesis.
    Ogata S; Misumi Y; Tsuji E; Takami N; Oda K; Ikehara Y
    Biochemistry; 1992 Mar; 31(9):2582-7. PubMed ID: 1347701
    [TBL] [Abstract][Full Text] [Related]  

  • 76. In vitro release of cholecystokinin octapeptide-like immunoreactivity from rat brain synaptosomes.
    Klaff LJ; Hudson A; Sheppard M; Tyler M
    S Afr Med J; 1981 Jan; 59(5):158-60. PubMed ID: 7455849
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Neuropeptides and their peptidases: Functional considerations.
    Littlewood GM; Iversen LL; Turner AJ
    Neurochem Int; 1988; 12(3):383-9. PubMed ID: 20501242
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The effects of various serine protease inhibitors on estrogen receptor steroid binding.
    Koffman B; Modarress KJ; Bashirelahi N
    J Steroid Biochem Mol Biol; 1991 May; 38(5):569-74. PubMed ID: 2039753
    [TBL] [Abstract][Full Text] [Related]  

  • 79. SEP-1 - a subtilisin-like serine endopeptidase from germinated seeds of Hordeum vulgare L. cv. Morex.
    Fontanini D; Jones BL
    Planta; 2002 Oct; 215(6):885-93. PubMed ID: 12355148
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Hypothermic effect of neuromedin N in mice and its potentiation by peptidase inhibitors.
    Dubuc I; Nouel D; Coquerel A; Menard JF; Kitabgi P; Costentin J
    Eur J Pharmacol; 1988 Jun; 151(1):117-21. PubMed ID: 3416919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.